Inogen (INGN) Shares Outstanding (2012 - 2026)
Inogen's (INGN) quarterly Shares Outstanding (Entity) came in at $26.7 million in Q2 2026, down 1.15% year-over-year from $27.0 million in Q2 2025, and down 2.32% quarter-over-quarter from $27.4 million in Q1 2026.
Analysis
Inogen (INGN) Shares Outstanding (2012 - 2026) Analysis & Trends
Inogen (INGN) has reported Shares Outstanding (Entity) for 15 consecutive years, with $26.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) fell 1.15% year-over-year to $26.7 million in Q2 2026; TTM through Jun 2026 was $26.7 million, a 1.15% decrease from a year earlier, with the FY2025 full-year figure at $27.2 million, up 13.93% from the prior year.
- Shares Outstanding (Entity) was $26.7 million for Q2 2026 at Inogen, down from $27.4 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $27.4 million in Q1 2026 and troughed at $22.8 million in Q1 2022.
- A 5-year average of $24.5 million and a median of $23.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) advanced 14.19% in 2025 and decreased 1.15% in 2026, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $22.9 million in 2022, then increased by 1.67% to $23.3 million in 2023, then advanced by 2.48% to $23.9 million in 2024, then rose by 13.93% to $27.2 million in 2025, then dropped by 1.84% to $26.7 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $26.7 million (Q2 2026), $27.4 million (Q1 2026), and $27.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 27.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.05 Mn |
| Mar 31, 2026 | 27.32 Mn |
| Dec 31, 2025 | 26.60 Mn |
| Sep 30, 2025 | 27.08 Mn |
| Jun 30, 2025 | 26.96 Mn |
| Mar 31, 2025 | 25.16 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 23.75 Mn |
| Jun 30, 2024 | 23.61 Mn |
| Mar 31, 2024 | 23.40 Mn |
| Dec 31, 2023 | 23.18 Mn |
| Sep 30, 2023 | 23.23 Mn |
| Jun 30, 2023 | 23.15 Mn |
| Mar 31, 2023 | 23.01 Mn |
| Dec 31, 2022 | 22.85 Mn |
| Sep 30, 2022 | 22.88 Mn |
| Jun 30, 2022 | 22.85 Mn |
| Mar 31, 2022 | 22.75 Mn |
| Dec 31, 2021 | 22.49 Mn |
| Sep 30, 2021 | 22.62 Mn |